Abstract
Palbociclib plus exemestane with GnRH agonist vs capecitabine in premenopausal patients with HR+/HER2- metastatic breast cancer: Updated survival results of the randomized phase 2 study Young-PEARL.
Author
person
Yeon Hee Park
Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea
info_outline
Yeon Hee Park, Kyung-Hun Lee, Gun Min Kim, Seok Yun Kang, Keun Seok Lee, Jee Hyun Kim, Kyoung Eun Lee, Hee Kyung Ahn, Moon Hee Lee, Hee Jun Kim, Hanjo Kim, Su-Jin Koh, Ji-Yeon Kim, Joohyuk Sohn, Sung-Bae Kim, Jin Seok Ahn, Seonwoo Kim, Hyun Cho, Kyung Hae Jung, Seock-Ah Im
Full text
Authors
person
Yeon Hee Park
Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea
info_outline
Yeon Hee Park, Kyung-Hun Lee, Gun Min Kim, Seok Yun Kang, Keun Seok Lee, Jee Hyun Kim, Kyoung Eun Lee, Hee Kyung Ahn, Moon Hee Lee, Hee Jun Kim, Hanjo Kim, Su-Jin Koh, Ji-Yeon Kim, Joohyuk Sohn, Sung-Bae Kim, Jin Seok Ahn, Seonwoo Kim, Hyun Cho, Kyung Hae Jung, Seock-Ah Im
Organizations
Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea, Seoul National University Hospital, Seoul, N/S, South Korea, Yonsei Cancer Center, Seoul, N/S, South Korea, Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, South Korea, Department of Oncology, National Cancer Center, Goyang-Si, South Korea, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South), Department of Hematology-Oncology, School of Medicine, Ewha Womans University, Seoul, South Korea, Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, South Korea, Inha University Hospital, Incheon, South Korea, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, South Korea, Division of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Hospital, Cheonan, South Korea, Ulsan University Hosp, University of Ulsan, Dong-Gu, South Korea, Samsung Medical Center, Seoul, South Korea, Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea, Samsung Medical Center, Gangnam-Gu, South Korea, LSK Global PS, Seoul, South Korea, Seoul National University Hospital, Seoul, South Korea
Abstract Disclosures
Clinical status
Clinical
36 organizations
3 drugs
5 targets
Organization
Samsung Medical CenterOrganization
Sungkyunkwan University School of MedicineOrganization
Seoul National University HospitalOrganization
Department of Hematology-OncologyOrganization
Ajou University School of MedicineOrganization
Seoul National University College of MedicineOrganization
Seoul National University Bundang HospitalOrganization
School of Medicine, Showa UniversityOrganization
Ewha Womans UniversityOrganization
Gachon University Gil Medical CenterOrganization
Inha University HospitalOrganization
Chung-Ang University College of MedicineOrganization
Division of Hematology and OncologyOrganization
Soonchunhyang University HospitalOrganization
Ulsan University HospitalOrganization
University of Ulsan College of MedicineOrganization
Asan Medical CenterOrganization
LSK Global PSOrganization
Department of Oncology, National Cancer CenterOrganization
Department of Hematology-Oncology, School of Medicine, Ewha Womans University, Seoul, South KoreaOrganization
Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical CenterOrganization
Division of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University HospitalOrganization
Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of MedicineOrganization
Samsung Medical Center, Gangnam-GuOrganization
Ulsan University Hospital, University of UlsanDrug
exemestaneDrug
palbociclibDrug
capecitabineTarget
CDK6Target
thymidylate synthaseTarget
CDK4 & 6Target
thymidine phosphorylaseTarget
exemestane